Natco Pharma Limited CC-Mar24.pdf · 2024-05-28
Congratulations for the excellent set of numbers. And as per the guidance, you have performed very well. So, congratulations to the entire team. So, my specific question is that we have taken a hit as far as API revenue is concerned for the last quarter. So, this is onetime, or this is going to be a regular feature. And the second question is regarding the Crop Health Science, wherein you have underutilized that division. So, you are planning to launch some products and buy some raw material and then it was discarded? What is it that Rs. 30 crores is you have accounted for?
So, that is one time. And you are targeting Rs. 300 crores in this segment in the coming couple of years, right?